Cihak J, Ziegler H W, Kölsch E
Immunology. 1981 May;43(1):133-43.
The non-secreting variant of ADJ-PC-5 plasma cell tumour of BALB/c mice is a highly malignant tumor, the LD50 being 3 x 10(1) cells/mouse after intraperitoneal injection. Nevertheless, immunization against the tumour is possible. Four injections of 10(7) X-irradiated tumour cells at weekly intervals render up to 95% of mice resistant to an otherwise lethal challenge with 10(3) living tumour cells. The immune responses are both T cell-mediated cellular cytotoxicity and antibody-mediated cytotoxicity as assessed by in vitro tests. Immunity can also be transferred in vivo into recipient mice by either spleen cells or immune sera. Specificity of both types of immune responses was determined. The results indicate that the cell-mediated and the humoral immune response are directed against cell-surface antigens associated with endogenous murine leukemia virus.
BALB/c小鼠的ADJ-PC-5浆细胞瘤的非分泌变体是一种高度恶性肿瘤,腹腔注射后的半数致死剂量为3×10¹个细胞/小鼠。然而,针对该肿瘤进行免疫是可行的。每周间隔注射4次10⁷经X射线照射的肿瘤细胞,可使高达95%的小鼠对10³个活肿瘤细胞的致死性攻击产生抗性。通过体外试验评估,免疫反应包括T细胞介导的细胞毒性和抗体介导的细胞毒性。免疫也可通过脾细胞或免疫血清在体内转移到受体小鼠中。确定了两种免疫反应的特异性。结果表明,细胞介导的和体液免疫反应均针对与内源性鼠白血病病毒相关的细胞表面抗原。